Literature DB >> 26011782

The contribution of mast cells to postoperative ileus in experimental and clinical studies.

E G Peters1,2, W J De Jonge2, B J J Smeets1, M D P Luyer1.   

Abstract

The persistent phase of postoperative ileus (POI) is mediated by inflammatory activation of the resident myeloid immune cell population in the gut wall, likely elicited by neurogenic activation. Mast cells are thought to play a critical role in this inflammatory response and involvement of mast cells in POI has been investigated and described thoroughly in experimental studies. Intestinal manipulation (IM) leads to degranulation of mast cells, resulting in an increase in mast cell proteases in peritoneal fluid and gut tissue. The inflammatory infiltrate formed in the intestinal wall thereby impairs gastrointestinal motility. In the clinical study by Berdun et al., the experimentally known association between mast cell degranulation and delayed motility is shown in a clinical setting. These findings are important and open up therapeutic opportunities to reduce or prevent POI. In this mini-review, the role of mast cells in POI is discussed. Furthermore, an update is given on the involvement of the inflammatory response in POI and potential therapeutic strategies.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  inflammation; mast cell degranulation; postoperative ileus; surgery

Mesh:

Year:  2015        PMID: 26011782     DOI: 10.1111/nmo.12579

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  8 in total

Review 1.  The Role of Inflammatory Mediators in the Development of Gastrointestinal Motility Disorders.

Authors:  Tibor Docsa; Adám Sipos; Charles S Cox; Karen Uray
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

2.  Functional characterization of oxazolone-induced colitis and survival improvement by vagus nerve stimulation.

Authors:  Elisa Meroni; Nathalie Stakenborg; Pedro J Gomez-Pinilla; Gert De Hertogh; Gera Goverse; Gianluca Matteoli; Simon Verheijden; Guy E Boeckxstaens
Journal:  PLoS One       Date:  2018-05-23       Impact factor: 3.240

Review 3.  Postoperative Ileus and Postoperative Gastrointestinal Tract Dysfunction: Pathogenic Mechanisms and Novel Treatment Strategies Beyond Colorectal Enhanced Recovery After Surgery Protocols.

Authors:  Elvio Mazzotta; Egina Criseida Villalobos-Hernandez; Juan Fiorda-Diaz; Alan Harzman; Fievos L Christofi
Journal:  Front Pharmacol       Date:  2020-11-24       Impact factor: 5.810

4.  Immune checkpoint inhibitor-induced colitis complicated with inflammatory intestinal obstruction: a case report and literature review.

Authors:  Shunde Tan; Gang Zhu; Jun Fan; Jianfei Chen; Xinkai Li; Yisheng Peng; Song Su; Cheng Fang; Xiaoli Yang; Bo Li
Journal:  Transl Cancer Res       Date:  2022-07       Impact factor: 0.496

Review 5.  Molecular and cellular mechanisms underlying postoperative paralytic ileus by various immune cell types.

Authors:  Chao Sui; Liang Tao; Chunhua Bai; Lihua Shao; Ji Miao; Kai Chen; Meng Wang; Qiongyuan Hu; Feng Wang
Journal:  Front Pharmacol       Date:  2022-08-03       Impact factor: 5.988

6.  Experimental postoperative ileus: is Th2 immune response involved?

Authors:  Sisi Lin; Florian Kühn; Tobias S Schiergens; Andrey A Zamyatnin; Orkhan Isayev; Eldar Gasimov; Jens Werner; Yongyu Li; Alexandr V Bazhin
Journal:  Int J Med Sci       Date:  2021-06-16       Impact factor: 3.738

7.  Degranulation of gastrointestinal mast cells contributes to hepatic ischemia-reperfusion injury in mice.

Authors:  Zhigang He; Yue Li; Sunqiang Ma; Muqing Yang; Yuanyuan Ma; Cheng Ma; Jian Song; Tianyu Yu; Siqi Zhang; Jiyu Li
Journal:  Clin Sci (Lond)       Date:  2018-10-29       Impact factor: 6.124

8.  Early oral nutrition improves postoperative ileus through the TRPA1/CCK1-R-mediated mast cell-nerve axis.

Authors:  Da-Li Sun; Yu-Xing Qi; Ting Yang; Yue-Ying Lin; Shu-Min Li; Yi-Jun Li; Qing-Wen Xu; Yan-Bo Sun; Wei-Ming Li; Xiong-Zhi Chen; Peng-Yuan Xu
Journal:  Ann Transl Med       Date:  2020-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.